Skip to main content

Clinuvel Pharmaceuticals Ltd

CUVL
Exchange
Nasdaq
Industry
American Depositary Receipts
SEC CIK
0001290877

No open-market purchases or sales by Clinuvel Pharmaceuticals Ltd insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesCLVLF

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026
0
13F valueReported value at the end of Q2 2026
$0
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding CUVL, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding CUVL at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Clinuvel Pharmaceuticals Ltd insiders from Form 4, newest first.

See all insider trades

No open-market purchases or sales by Clinuvel Pharmaceuticals Ltd insiders are on file.

Top 10 13F holders, Q2 2026

The largest institutional positions in Clinuvel Pharmaceuticals Ltd at the end of Q2 2026; share changes are against Q1 2026.

View all: Top 10 13F holders, Q2 2026

No institution reported holding CUVL in 13F filings for Q2 2026.